Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Credit agrmnt [a] Appointed director Quarterly results Director departure
|
ANGIOTECH PHARMACEUTICALS INC (ANPMF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/25/2012 |
4
| Highland Crusader Offshore Partners, L.P. (10% Owner) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Sold 1,115,000 shares
@ $15.43, valued at
$17.2M
|
|
06/14/2012 |
3
| Highland Crusader Offshore Partners, L.P. (10% Owner) has filed a Form 3 on ANGIOTECH PHARMACEUTICALS INC |
05/17/2011 |
4/A
| Neske Tammy (SVP, Human Resources) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 3,000 shares
@ $0 Disposed of 3,300 shares
@ $0 Disposed of 5,500 shares
@ $0 Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 50,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Gross Jeffrey M (SVP, Research & Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 9,000 shares
@ $0 Disposed of 6,000 shares
@ $0 Disposed of 1,500 shares
@ $0 Disposed of 2,000 shares
@ $0 Disposed of 20,000 shares
@ $0 Disposed of 12,500 shares
@ $0 Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 100,000 options to buy
@ $0 Disposed of 25,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Diaz Victor Manuel (SVP, Global Manufacturing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 150,000 options to buy
@ $0.27, valued at
$40.5k
Disposed of 150,000 options to buy
@ $0.16, valued at
$24k
Disposed of 30,000 options to buy
@ $5.69, valued at
$170.7k
|
|
05/17/2011 |
4/A
| Bryant Steven R. (SVP, Specialty Medical Device) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 19,261 options to buy
@ $15.44, valued at
$297.4k
Disposed of 15,000 options to buy
@ $7.65, valued at
$114.8k
Disposed of 25,000 options to buy
@ $0.26, valued at
$6.5k
Disposed of 22,000 options to buy
@ $0.27, valued at
$5.9k
Disposed of 50,000 options to buy
@ $1.05, valued at
$52.5k
|
|
05/17/2011 |
4/A
| Cunliffe Sean (SVP, Sales & Marketing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 70,700 shares
@ $0 Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 100,000 options to buy
@ $1.28, valued at
$128k
|
|
05/17/2011 |
4/A
| Dent Jay Bernard (SVP, Finance) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 6,000 shares
@ $0 Disposed of 8,000 shares
@ $0 Disposed of 2,700 shares
@ $0 Disposed of 35,000 options to buy
@ $0 Disposed of 75,000 options to buy
@ $0 Disposed of 70,000 options to buy
@ $0 Disposed of 65,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Bailey K Thomas (CFO) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 15,000 shares
@ $0 Disposed of 1,100 shares
@ $0 Disposed of 13,900 shares
@ $0 Disposed of 160,000 options to buy
@ $1.05, valued at
$168k
Disposed of 250,000 options to buy
@ $0.27, valued at
$67.5k
Disposed of 250,000 options to buy
@ $0.16, valued at
$40k
Disposed of 200,000 options to buy
@ $7.65, valued at
$1.5M
|
|
05/17/2011 |
4/A
| McMasters David (SVP, Legal) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 2,000 shares
@ $0 Disposed of 800 shares
@ $0 Disposed of 135,000 options to buy
@ $1.05, valued at
$141.8k
Disposed of 200,000 options to buy
@ $0.27, valued at
$54k
Disposed of 200,000 options to buy
@ $0.16, valued at
$32k
Disposed of 50,000 options to buy
@ $13.468, valued at
$673.4k
Disposed of 175,000 options to buy
@ $7.65, valued at
$1.3M
|
|
05/17/2011 |
4/A
| Hunter William L (CEO & President) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 435,356 shares
@ $0 Disposed of 375,000 shares
@ $0 Disposed of 102,000 shares
@ $0 Disposed of 3,332,616 shares
@ $0 Disposed of 567,595 shares
@ $0 Disposed of 156,933 shares
@ $0 Disposed of 33,000 shares
@ $0 Disposed of 89,692 shares
@ $0 Disposed of 40,848 shares
@ $0 Disposed of 53,000 shares
@ $0 Disposed of 30,500 shares
@ $0 |
|
05/16/2011 |
4
| Hunter William L (CEO & President) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 435,356 shares
@ $0.17, valued at
$74k
Disposed of 375,000 shares
@ $0.17, valued at
$63.8k
Disposed of 102,000 shares
@ $0.17, valued at
$17.3k
Disposed of 3,332,616 shares
@ $0.17, valued at
$566.5k
Disposed of 567,595 shares
@ $0.15, valued at
$85.1k
Disposed of 156,933 shares
@ $0.16, valued at
$25.1k
Disposed of 33,000 shares
@ $0.2, valued at
$6.6k
Disposed of 89,692 shares
@ $0.31, valued at
$27.8k
Disposed of 40,848 shares
@ $0.32, valued at
$13.1k
Disposed of 53,000 shares
@ $0.31, valued at
$16.4k
Disposed of 30,500 shares
@ $0.42, valued at
$12.8k
|
|
05/16/2011 |
4
| Dent Jay Bernard (SVP, Finance) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 8,000 shares
@ $1.95, valued at
$15.6k
Disposed of 2,700 shares
@ $1.94, valued at
$5.2k
Disposed of 35,000 options to buy
@ $0 Disposed of 75,000 options to buy
@ $0 Disposed of 70,000 options to buy
@ $0 Disposed of 65,000 options to buy
@ $0 Disposed of 6,000 shares
@ $1.94, valued at
$11.6k
|
|
05/16/2011 |
4
| Cunliffe Sean (SVP, Sales & Marketing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 70,700 shares
@ $0 Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 100,000 options to buy
@ $1.28, valued at
$128k
|
|
05/16/2011 |
4
| McMasters David (SVP, Legal) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 2,000 shares
@ $0 Disposed of 800 shares
@ $0 Disposed of 135,000 options to buy
@ $1.05, valued at
$141.8k
Disposed of 200,000 options to buy
@ $0.27, valued at
$54k
Disposed of 200,000 options to buy
@ $0.16, valued at
$32k
Disposed of 50,000 options to buy
@ $13.468, valued at
$673.4k
Disposed of 175,000 options to buy
@ $7.65, valued at
$1.3M
|
|
05/16/2011 |
4
| Bryant Steven R. (SVP, Specialty Medical Device) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 19,261 options to buy
@ $15.44, valued at
$297.4k
Disposed of 15,000 options to buy
@ $7.65, valued at
$114.8k
Disposed of 25,000 options to buy
@ $0.26, valued at
$6.5k
Disposed of 22,000 options to buy
@ $0.27, valued at
$5.9k
Disposed of 50,000 options to buy
@ $1.05, valued at
$52.5k
|
|
05/16/2011 |
4
| Neske Tammy (SVP, Human Resources) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 3,000 shares
@ $1.91, valued at
$5.7k
Disposed of 3,300 shares
@ $1.9, valued at
$6.3k
Disposed of 5,500 shares
@ $1.35, valued at
$7.4k
Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 50,000 options to buy
@ $0 |
|
05/16/2011 |
4
| Gross Jeffrey M (SVP, Research & Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 9,000 shares
@ $1.11, valued at
$10k
Disposed of 6,000 shares
@ $1.68, valued at
$10.1k
Disposed of 1,500 shares
@ $1.72, valued at
$2.6k
Disposed of 2,000 shares
@ $1.8, valued at
$3.6k
Disposed of 20,000 shares
@ $1.77, valued at
$35.4k
Disposed of 12,500 shares
@ $1.85, valued at
$23.1k
Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 100,000 options to buy
@ $0 Disposed of 25,000 options to buy
@ $0 |
|
05/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/16/2011 |
4
| Diaz Victor Manuel (SVP, Global Manufacturing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 150,000 options to buy
@ $0.27, valued at
$40.5k
Disposed of 150,000 options to buy
@ $0.16, valued at
$24k
Disposed of 30,000 options to buy
@ $5.69, valued at
$170.7k
|
|
04/16/2010 |
3/A
| Bryant Steven R. (SVP, Specialty Medical Device) has filed a Form 3/A on ANGIOTECH PHARMACEUTICALS INC |
03/30/2010 |
4/A
| Willms Arthur H (Director) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 12,500 options to buy
@ $0 |
|
03/26/2010 |
4
| Gross Jeffrey M (SVP, Research & Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Bought 9,000 shares
@ $1.11, valued at
$10k
|
|
03/09/2010 |
4
| Dent Jay Bernard (SVP, Finance) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 35,000 options to buy
@ $1.09, valued at
$38.2k
|
|
03/09/2010 |
4
| Bryant Steven R. (SVP, Specialty Medical Device) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 50,000 options to buy
@ $1.05, valued at
$52.5k
|
|
03/09/2010 |
4
| Diaz Victor Manuel (SVP, Global Manufacturing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 85,000 options to buy
@ $1.05, valued at
$89.3k
|
|
03/09/2010 |
4
| Cunliffe Sean (SVP, Sales & Marketing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 85,000 options to buy
@ $1.05, valued at
$89.3k
|
|
03/09/2010 |
4
| McMasters David (SVP, Legal & General Counsel) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 135,000 options to buy
@ $1.05, valued at
$141.8k
|
|
03/09/2010 |
4
| Bailey K Thomas (CFO) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 160,000 options to buy
@ $1.05, valued at
$168k
|
|
03/09/2010 |
4
| Chen Jonathan W (SVP, Business Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 85,000 options to buy
@ $1.09, valued at
$92.7k
|
|
03/09/2010 |
4
| Neske Tammy (SVP, Human Resources) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 85,000 options to buy
@ $1.09, valued at
$92.7k
|
|
03/09/2010 |
4
| Gross Jeffrey M (SVP, Research & Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 85,000 options to buy
@ $1.09, valued at
$92.7k
|
|
03/09/2010 |
4
| Avelar Rui (Chief Medical Officer) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 135,000 options to buy
@ $1.09, valued at
$147.2k
|
|
03/09/2010 |
4
| Hunter William L (President and CEO) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 300,000 options to buy
@ $1.09, valued at
$327k
|
|
|
|
|